Monika Looijen-Salamon

Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma

Olga C.J. Schuurbiers, Tineke W.H. Meijer, J.H.A.M. Kaanders et al. · Journal of Thoracic Oncology · 2014 · 132 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4

Tineke W.H. Meijer, Olga C.J. Schuurbiers, Johannes H.A.M. Kaanders et al. · Lung Cancer · 2011 · 117 citations

Medicine, Molecular Biology, Oncology +14

A Brief Retrospective Report on the Feasibility of Epidermal Growth Factor Receptor and KRAS Mutation Analysis in Transesophageal Ultrasound- and Endobronchial Ultrasound-Guided Fine Needle Cytological Aspirates

Olga C.J. Schuurbiers, Monika Looijen-Salamon, Marjolijn J. L. Ligtenberg · Journal of Thoracic Oncology · 2010 · 111 citations · Full text

Medicine, Pathology, Neoplasia +11

Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy

Maarten J. van der Doelen, Niven Mehra, Inge M. van Oort et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 79 citations · Full text

Medicine, Oncology, Urology +17

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non–Small Cell Lung Cancer

Anthonie J. van der Wekken, R. Pelgrim, N. 't Hart et al. · Clinical Cancer Research · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16